See veebileht kasutab küpsiseid kasutaja sessiooni andmete hoidmiseks. Veebilehe kasutamisega nõustute ETISe kasutustingimustega. Loe rohkem
Olen nõus

Siiri Kõljalg

https://www.etis.ee/CV/Siiri_Kõljalg/est
737 4178
siiri.koljalg@ut.ee

Teenistuskäik

Töökohad ja ametid
2006–...   
Tartu Ülikool, Arstiteaduskond, Mikrobioloogia instituut, Erakorraline teadur (1,00)
01.09.1999–...   
SA Tartu Ülikooli Kliinikum, Tartu Ülikooli Klliinikumi ühendlabor, laboriarst (0,50)
01.01.1999–...   
Tartu Ülikool, Arstiteaduskond, Mikrobioloogia instituut, Meditsiinilise mikrobioloogia ja viroloogia õppetool; teadur
1991-1993 SA TÜK internatuur
01.11.2016–30.11.2017   
Tartu Ülikool, Meditsiiniteaduste valdkond, bio- ja siirdemeditsiini instituut, meditsiinilise mikrobioloogia teadur (0,50)
01.01.2016–31.10.2016   
Tartu Ülikool, Meditsiiniteaduste valdkond, bio- ja siirdemeditsiini instituut, meditsiinilise mikrobioloogia teadur (0,50)
01.11.2013–31.12.2015   
Tartu Ülikool, Arstiteaduskond, Mikrobioloogia instituut, meditsiinilse mikrobioloogia teadur (0,50)
01.11.2010–31.10.2013   
Tartu Ülikool, Arstiteaduskond, Mikrobioloogia instituut, meditsiinilise mikrobioloogia teadur (0,50)
01.11.2007–31.10.2010   
Tartu Ülikool, Arstiteaduskond, Mikrobioloogia instituut, mikrobioloogia teadur (0,50)
2007–2010   
Tartu Ülikool, Arstiteaduskond, Mikrobioloogia instituut, Meditsiinilise mikrobioloogia ja viroloogia õppetool, mikrobioloogia teadur (1,00)
01.11.2004–31.10.2007   
Tartu Ülikool, Arstiteaduskond, Mikrobioloogia instituut, mikrobioloogia erakorraline teadur (0,50)
 
 
Haridustee
1983-1989 Tartu Ülikool, arstiteaduskond
1993-1998 Tartu Ülikool, doktorant

Kvalifikatsioon

Teaduskraadid
Siiri Kõljalg, doktorikraad, 1999, (juh) Marika Mikelsaar, Acinetobacter - an important nosocomial pathogen, Tartu Ülikool, Arstiteaduskond, Mikrobioloogia instituut.
 
 
Teadustöö põhisuunad
VALDKOND: 3. Terviseuuringud; 3.11. Terviseuuringutega seotud uuringud, näiteks biokeemia, geneetika, mikrobioloogia, biotehnoloogia, molekulaarbioloogia, rakubioloogia, biofüüsika ja bioinformaatika; PÕHISUUND: Hospitaalinfektsioonid. Infektsioonide epidemioloogia ja antibiootikumresistentsus
 
 
Lisainfo
meditsiinidoktor
Tartu Ülikool 1999

Jooksvad projektid

Lõppenud projektid

Juhendatud väitekirjad

Publikatsioonid

Klass
Aasta
Publikatsioon
 
1.1.
2017
Ahonen, M.; Kahru, A.; Ivask, A.; Kasemets, K.; Kõljalg,S.; Mantecca, P.; Vinković Vrček, I.; Keinänen-Toivola, M.; Crijns, F. (2017). Proactive Approach for Safe Use of Antimicrobial Coatings in Healthcare Settings: Opinion of the COST Action Network AMiCI. International Journal of Environmental Research and Public Health, 14 (4), 366.10.3390/ijerph14040366.
1.1.
2016
Mändar, Karsten; Sõber, Tiina; Kõljalg, Siiri; Rööp, Tiiu; Mändar, Reet; Sepp, Epp. (2016). Microbiological contamination of the euro currency in Estonia. Infectious Diseases, 48 (10), 772−774.10.1080/23744235.2016.1201725.
1.1.
2016
Bielicki, J.A., Sharland, M., Johnson, A.P., Henderson, K.L., Cromwell, D.A. , Berger, C., Esposito, S., Danieli, E., Tenconi, R., Folgori, L., Bernaschi, P., Santiago, B., Saavedra, J., Cercenado, E., Brett, A., Rodrigues, F., Cizman, M., Jazbec, J., Babnik, J., Pavčnik, M., Pirš, M., Mueller Premrov, M., Lindner, M., Borte, M., Lippmann, N., Schuster, V., Thürmer, A., Lander, F., Elias, J., Liese, J., Durst, A., Weichert, S., Schneider, C., Hufnagel, M., Rack, A., Hübner, J., Dubos, F., Lagree, M., Dessein, R., Tissieres, P., Cuzon, G., Gajdos, V., Doucet-Populaire, F., Usonis, V., Gurksniene, V., Bernatoniene, G., Tsolia, M., Spyridis, N., Lebessi, E., Doudoulakakis, A., Lutsar, I., Kõljalg, S., Schülin, T., Warris, A. (2016). Selecting appropriate empirical antibiotic regimens for paediatric bloodstream infections: Application of a Bayesian decision model to local and pooled antimicroabial resistance surveillance data. Journal of Antimicrobial Chemotherapy, 71 (3), 794−802.10.1093/jac/dkv397.
5.2.
2016
Pavelkovich, A.; Ivanova, M.; Kõljalg, S.; Naaber, P.; Pai, K.; Sepp, E.; BEEp research team (2016). Epidemiology of AB resistant gram-negative bacteria in the Baltic Sea region. Eesti Arst, 95 (Supplement1): XIII Baltic Congress in Laboratory Medicine; Tartu, Estonia; May 12-14 2016. OÜ Celsius Healthcare, 39.
5.2.
2015
Naaber, Paul; Balode, Arta; Egorova, Svetlana; Huik, Kristi; Ivanova, Marina; Kaftyreva, Lidia; Kõljalg, Siiri; Kõressaar, Triinu; Lillo, Jana; Löhr, Iren; Miciuleviciene, Jolanta; Pai, Kristiine; Pavelkovich, Anastassia; Remm, Maido; Sepp, Epp (2015). The epidemiology of CTX-M group genes among clinical Escherichia coli strains in Estonia, Latvia, Lithuania, Norway and Russia.
5.2.
2015
Truusalu, Kai; Vainumäe, Inga; Stsepetova, Jelena; Smidt, Imbi; Sepp, Epp; Mikelsaar, Marika; Kõljalg, Siiri (2015). The impact of the initial antibiotic treatment to subsequent recurrences in childhood urinary tract infection caused by Escherichia coli: beta-lactams vs gentamicin. In: .ECCMID 2015 Copenhagen, Denmark, 25-28 April 2015. ECCMID 2015 Copenhagen, Denmark, 25-28 April 2015.
1.1.
2014
Kõljalg, S.; Telling, K.; Huik, K.; Murruste, M.; Saarevet, V.; Pauskar, M.; Lutsar, I. (2014). First report of Wohlfahrtiimonas chitiniclastica from soft tissue and bone infection at an unusually high northern latitude. Folia Microbiologica, 60 (2), 155−158.10.1007/s12223-014-0355-x.
1.1.
2014
Lillo, Jana; Pai, Kristiine; Bolde, Arta; Makarova, Mariia; Huik, Kristi; Kõljalg, Siiri; Ivanova, Marina; Kaftyreva, Lidia; Miciuleviciene, Jolanata; Naaber, Paul; Parv, Kristel; Pavelkovich, Anastasia; Rööp, Tiiu; Toompere, Karolin; Suzhaeva, Ludmila; Sepp, Epp (2014). Differences in extended-spectrum beta-lactamase producing Escherichia coli virulence factor genes in the Baltic Sea region. BioMed Research International, 427254, 1−7.10.1155/2014/427254.
1.1.
2014
Pavelkovich, Anastasia; Balode, Arta; Edquist, Petra; Egorova, Svetlana; Ivanova, Marina; Kaftyreva, Lidia; Konovalenko, Irina; Kõljalg, Siiri; Lillo, Jana; Lipskaya, Lidia; Miciuleviciene, Jolanta; Pai, Kristiine; Parv, Kristel; Pärna, Katri; Rööp, Tiiu; Sepp, Epp; Štšepetova, Jelena; Naaber, Paul (2014). Detection of Carbapenemase-Producing Enterobacteriaceae in the Baltic Countries and St. Petersburg Area. BioMed Research International, 2014, Article 548960.10.1155/2014/548960.
1.1.
2014
Kõljalg, Siiri; Truusalu, Kai; Štšepetova, Jelena; Pai, Kristiine; Vainumäe, Inga; Sepp, Epp; Mikelsaar, Marika (2014). The Escherichia coli phylogenetic group B2 with integrons prevails in childhood recurrent urinary tract infections. APMIS, 122 (5), 452−458.10.1111/apm.12167.
1.2.
2014
Rätsep, Merle; Naaber, Paul; Kõljalg, Siiri; Shkut, Elena; Sepp, Epp (2014). Effect of Lactobacillus Strain on Clinical Isoletes of Clostridium difficile in vitro. Journal of Probiotics and Health, 2, 1−5.10.4172/2329-8901.1000119.
5.1.
2014
Truusalu, K; Smidt, I; Hütt, P; Stsepetova, J; Vainumäe, I; Sepp, E; Mikelsaar, M; Kõljalg, S. (2014). Comparison of phylogenetic groups, antibacterial resistance and integron containment of Escherichia coli from initial episode of childhood urinary tract infections with different outcomes. 24th European Congress of Clinical Microbiology and Infectious Diseases in Barcelona, Spain, 10 – 13 May 2014.. x, x.
5.2.
2014
Pärna, K.; Balode, A.; Edquist, A.; Egorova, P.; Kaftyreva, S.; Miciuleviciene, L.; Ivanova, M.; Kõljalg, S.; Pai, K.; Pavelkovich, A.; Rööp, T.; Sepp, E.; Naaber, P.; Stsepetova, J. (2014). Detection of class 1, 2 and 3 integrons among extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated from Baltic sea region. European Congress of Cilinical Microbiology and Infestious Diseases, Barcelona, Spain, 10-13 May 2014. x, x.
5.2.
2014
Pai, K.; Huik, K.; Ivanova, M.; Kõljalg, S.; Pavelkovich, K.; Parv, K.; Rööp, T.; Sepp, E.; Naaber, P. (2014). Detection and molecular characterisation of extended-spectrum beta-lactamase-producing Escherichia coli sequence type ST131 from the Baltic region. European Congress of Clinical Microbiology and Infectious Diseases, Barcelona, Spain, 10-13 May 2014.
1.1.
2013
Brilene, T.; Soeorg, H.; Kiis, M.; Sepp, E.; Kõljalg, S.; Lõivukene, K.; Jürna-Ellam, M.; Kalinina, J.; Stšepetova, J.; Metsvaht, T.; Lutsar, I. (2013). In vitro synergy of oxacillin and gentamicin against coagulase-negative staphylococci from blood cultures of neonates with late-onset sepsis. APMIS, 121 (9), 859−864.10.1111/apm.12048.
1.3.
2013
Егорова, СА; Кафтыреща, ЛА; Липская, ЛВ; Коноваленко, ИБ; Пясетская, МФ; Курчикова, ТС; Ведерникова, НБ; Морозова, ОТ; Смирнова, МБ; Попенко, ЛН; Любушкина, МИ; Савочкина, ЮА; Макарова, МА; Сужаева, ЛВ; Останкова, ЮВ; Иванова, МН; Павелкович, АМ; Наабер, П; Сепп, Э; Кыльялг, С ... Балоде, А. (2013). Штаммы энтеробактерий, продуцирующие бета-лактамазы пасширенного спектра и металло-В-лактамазу НДМ-1, выделенные в стационарах в странах Балтийского региона. Инфекция и иммунитет, 3 (1), 29−36.
5.2.
2013
Lillo, J; Balode, A; Egorova, S; Huik, K; Ivanova, M; Kaftyreva, L; Makarova, M; Miciuleviciene, J; Naaber, P; Pai, K; Parv, K; Pavelkovich, A; Rööp, T; Sepp, E. (2013). Differences in virulence factors of Escherichia coli isolated from the Baltic Sea region. 23 nd European Congress ofClinical Microbiology and Infectious Diseases; Berlin; 27-30 April 2013.
5.2.
2013
Naaber, P; Balode, A; Djundika, T; Egorova, S; Huik, K; Kaftyreva, L; Kamõnina, N; Kirs, K; Kõljalg, S; Konovalenko, I; Kurchikova, T; Lillo, J; Lipskaya, L; Lõivukene, L; Makarova, M; Makstutis, G; Miciuleviciene, J; Morozova, O; Pai, K; Parv, K ... Ivanova, M (2013). Epidemiology of extended-spectrum beta-lactamases-producing Escherichia coli and Klebsiella pneumoniae in the Baltic Sea region. 23 nd European Congress ofClinical Microbiology and Infectious Diseases; Berlin; 27-30 April 2013.
5.2.
2013
Pai, K; Balode, B; Egorova, S; Huik, K; Ivanova, M; Kaftyreva, L; Kõljalg, S; Lillo, J; Miciuleviciene, J; Naaber, P; Parv, K; Pavelkovich, A; Rööp, T; Sepp, E. (2013). The molecular epidemiology of extended-spectrum beta-lactamases-producing Escherichia coli and Klebsiella pneumoniae in the Baltic Sea region. 23 nd European Congress ofClinical Microbiology and Infectious Diseases; Berlin; 27-30 April 2013.
5.2.
2013
Rätsep, Merle; Naaber, Paul; Kõljalg, Siiri; Smidt, Imbi; Shkut, Leena; Sepp, Epp (2013). Antagonistic activity of culture supernatant of lactobacilli against the growth of Clostridium difficile in vitro. ClostPath 2013 Meeting; Palm Cove, Australia; 22.-26. October 2013.
5.2.
2013
Pavelkovich, A; Balode, A; Edquist, P; Egorova, S; Ivanova, M; Kaftyreva, L; Kõljalg, S; Lillo, J; Lipskaya, L; Miciuleviciene, J; Pai, K; Sepp, E; Sparbier, K; Naaber, P (2013). Detection of carbapenem-non-susceptible Escherichia coli and Klebsiella pneumoniae in the Baltic Sea region. 23nd European Congress ofClinical Microbiology and Infectious Diseases; Berlin; 27-30 April 2013..
1.1.
2012
Songisepp, E.; Hütt, P.; Rätsep, M.; Shkut, E.; Kõljalg, S.; Truusalu, K.; Stsepetova, J.; Smidt, I.; Kolk, H.; Zagura, M.; Mikelsaar, M. (2012). Safety of probiotic cheese containing Lactobacillus plantarum Tensia according to a variety of health indices in different age groups. Journal of Dairy Science, 95 (10), 5495−5509.dx.doi.org/10.3168/jds.2011-4756.
5.2.
2012
Kõljalg, S.; Truusalu, K.; Stsepetova, J.; Pai, K.; Vainumäe, I.; Hütt, P.; Smidt, I.; Mändar, R.; Sepp, E.; Mikelsaar, M. (2012). The role of phylogenetic groups of Escherichia coli in childhood recurrent urinary tract infections. 22nd European Congress ofClinical Microbiology and Infectious Diseases, London, United Kingdom, 31 March – 3 April 2012.
5.2.
2012
Naaber, P.; Sepp, E.; Pai, K.; LilĮo, J.; Pavelkovich, A.; Stsepetova, J .; Ivanova, M.; Lõįvukene, K.; Kõljalg, S. (2012). Molecular Epidemiology of Extended Spectrum Beta-Lactamases (ESBLs) in Estonia. BIT's 2nd Annual World Congress of Microbes-2012(WCM-2012), Guangzhou, China, July 30-August 1, 2012.
5.2.
2012
Kõljalg, S.; Naaber, P.; Rätsep, M.; Smidt, I.; Shkut, J.; Jaanimäe, L.; Löhr, L.H; ,Stsepetova, J.; Mändar, R.; Sepp, E. (2012). Population dynamics and sporulation of quinolone resistant and sensitive Clostridium difficile strains in different environmental conditions. 4th International Clostridium difficile Symposium; Bled, Slovenia, September 20-22, 2012.
1.1.
2011
Sepp, Epp; Stšepetova, Jelena; Smidt, Imbi; Rätsep, Merle; Kõljalg, Siiri; Lõivukene, Krista; Mändar, Reet; Jaanimäe, Liis; Löhr, IH; Natås, OB; Naaber, Paul (2011). Intestinal lactoflora in Estonian and Norwegian patients with antibiotic associated diarrhea. Anaerobe, 17, 407−409.
1.1.
2011
Naaber, Paul; Stsepetova, Jelena; Smidt, Imbi; Rätsep, Merle; Kõljalg, Siiri; Lõivukene, Krista; Jaanimäe, Liis; Löhr, Iren; Natås, Olav; Truusalu, Kai; Sepp, Epp (2011). Quantification of Clostridium difficile in Antibiotic-Associated Diarrhea Patients. Journal of Clinical Microbiology, 49 (10), 3656−3658.10.1128/JCM.05115-11.
5.2.
2011
Tiina, Drell; Jelena, Stsepetova; Irja, Lutsar; Tuuli, Metsvaht; Ülle, Parm; Kaja, Julge; Mari-Liis, Ilmoja; Maie, Jürisson; Siiri, Kõljalg; Paul, Naaber; Epp, Sepp (2011). Application of quantitative Real-time PCR for investigation on intestinal microbiota in pre-and full-term infants. 2nd ASMET-The ASM Emerging Technologies Conference: ASMET Conferences; San Juan, Pueto Rico; March 8-11, 2011. 45−46.
5.2.
2011
Naaber, Paul; Jelena , Stsepetova; Imbi, Smidt; Elena, Shkut; Merele, Rätsep; Siiri, Kõljalg; krista, Lõivukene; Reet, Mändar; Iren, Löhr; Olav, Natas; Epp, Sepp (2011). Application of molecular methods for invetigation og intestinallactoflora and Clostridium difficile in antibiotic-associated diarrhea patients. 2nd ASMET-The ASM Emerging Technologies Conference: ASMET Conferences; San Juan, Pueto Rico; March 8-11, 2011. USA, 41−42.
5.2.
2011
Kõljalg, S.; Stsepetova, J.; Smidt, I., Löhr, I; Truusalu, K.; Naaber, P.; Sepp, E. (2011). Antibiotic susceptibility, class I integrons and sporulation activity of Clostridium difficile strains from antibiotic-associated diarrhoea patients in two different years in Estonia and Norway. 21th ECCMID Milano, Italy 7-10 May 2011.
5.2.
2011
Naaber, P.; Smidt, I.; Rätsep, M.; Kõljalg, S.; Shkut, E.; Sepp, E. (2011). Strain-specific susceptibility of Clostridium difficile to inhibitory activity of Lactobacillus plantarum in vitro. 7th International Conference on the Molecular Biology and Pathogenesis of the Clostridia, 2011 Ames, Iowa USA.
5.2.
2011
Kõljalg, S.; Rätsep, M.; Stsepetova, J.; Smidt, I.; Shkut, E.; Naaber, P.; Sepp, E. (2011). Sporulation level of Clostridium difficile integron positive and negative strains in the presence of lactobacilli. 7th International Conference on the Molecular Biology and Pathogenesis of the Clostridia, 2011 Ames, Iowa USA.
5.2.
2011
Songisepp, Epp; Hütt, Pirje; Rätsep, Merle; Shkut, Elena; Zilmer, Mihkel; Kõljalg, Siiri; Truusalu, Kai; Smidt, Imbi; i Kolk, Helg; Zagura, Maksim; Mikelsaar, Marika (2011). Safety of a probiotic cheese comprising L. plantarum TENSIA according variety of health indices in different age groups. 6th Probiotics Prebiotics New Foods. 48.
1.3.
2010
Lõivukene, Krista; Adamson, Vivika; Mitt, Piret; Kõljalg, Siiri; Sepp, Epp; Ivanova, Marina; Jürna-Ellam, Marika; Kirs, Kaisa; Nurk, Allan; Rõõm, Aino; Truusalu, Kai; Naaber, Paul (2010). Metitsilliiniresistentse Staphylococcus aureus’e osakaal, esmasavaldumus ja antibiootikumiresistentsus Eestis. Eesti Arst, 89 (10), 630−636.
5.1.
2010
Naaber, Paul; Stsepetova, Jelena; Smidt, Imbi; Shkut, Elena; Rätsep, Merele; Kõljalg, Siiri; Lõivukene, Krista; Mänadar, Reet; Löhr, Irene; Natas, Borg; Sepp, Epp (2010). Intestinal Lactroflora in Patients with Antibiotic Associated Diarrhea (AAD). XXXIII Inernational Congress on Microbial Ecology and Diseases, Greece 6-10 September 2010. Greece, 22.
5.2.
2010
Smidt, I.; Sepp, E.; Rätsep, M.; Kõljalg, S.; Lõivukene, K.; Löhr, I.; Natas, O.; Mändar, R.; Naaber, P. (2010). Quantitative evaluation of Clostridium difficile and intestinal lactobacilli in patients with associated diarrhoea. Clinical Microbiology and Infection, 16: 20th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria 10-13 april 2010. S575. (2).
5.2.
2010
Naaber, P.; Truusalu, K.; Smidt, I.; Kõljalg, S.; Sepp, E.; Hütt, P.; Mändar, R.; Mikelsaar, M. (2010). Protective effect of xylitol and lactobacilli against Clostridium difficile infection in hamster model. Clinical Microbiology and Infection, 16 : 20th ECCMID, Vienna, Austria 10-13 April 2010. (2).
5.2.
2010
Arbo, Triin; Arbonen, Anne; Sepp, Epp; Stsepetova, Jelena; Kõljalg, Siiri; Lõivukene, Krista (2010). Eestist isoleeritud metitsilliinresistentse Staphylococcus aureus'e feno-ja genotüübilise diagnostika võrdlus. Eest Arst, 9: TÜ Arstiteaduskonna aastapäev 2010. 605.
5.2.
2010
Naaber, Paul; Stsepetova, Jelena; Smidt, Imbi; Shkut, Elena; Rätsep, Merle; Kõljalg, Siiri; Lõivukene, Krista; Mändar, Reet; Löhr, Irene; Natas, Borg; Sepp, Epp (2010). Intestinal Lactroflora in Patients with Antibiotic Associated Diarrhea (AAD). XXXIII International Congress of the Society for Microbial Ecology in Health and Disease; Greece; September 6-10, 2010. 22.
1.1.
2009
Sepp, E.; Stsepetova, J.; Lõivukene, K.; Truusalu, K.; Kõljalg, S.; Naaber, P.; Mikelsaar, M. (2009). The occurrence of antimicrobial resistance and class 1 integrons among commensal Escherichia coli isolates from infants and elderly persons. Annals of Clinical Microbiology and Antimicrobials, 8 (34), 1−6.
1.1.
2009
Kõljalg, S.; Truusalu, K.; Vainumäe, I.; Štšepetova, J.; Sepp, E.; Mikelsaar, M. (2009). Persistence of Escherichia coli clones and phenotypic and genotypic antibiotic resistance in recurrent tract infections in childhood. Journal of Clinical Microbiology, 47 (1), 99−105.10.1128/JCM.01419-08.
3.4.
2009
Songisepp, E.; Zilmer, M.; Hütt, P., Rätsep, M.; Utt, M.; Üksti, J.; Kõljalg, S.; Zilmer, K.; Mikelsaar, M. (2009). Lactobacillus plantarum TENSIA™ (DSM 21380) as a novel probiotic. Гастроэнтерология Санкт-Петербурга, 4. A25.
5.2.
2009
Lõivukene, K; Adamson, V; Ivanova, M; Jürna-Ellam, M; Kirs, K; Kõljalg, S; Mitt, P; Nurk, A; Rõõm, A; Sepp, E;i Truusalu, K; Naaber, P. (2009). Incidence and antimicrobial susceptibility pattern of methicillin-resistant Staphylococcus aureus isolates in Estonia.
5.2.
2009
Sepp, E.; Kõjalg, S.; Stsepetova, J., Smidt, I.; Rätsep, M.; Jaanimäe, L.; Naaber, P. (2009). Quantitative evaluation of lactobacilli and Clostridium difficile in faeces of patients with antibiotic associated diarrhoea and antibiotic resistance isolated strains. Fostering Cross-disciplinary Applied Research in Microbiology and Microbial Biotechnology: III International Conference on Environmental, Industrial and Applied Microbiology, BioMicroWorld 2009; Lisboa, Portugal; 2.-4.12.2009. 543.
5.2.
2009
Löhr, I.; Jaanimäe, L.; Kindingstad, L.; Kõljalg, S.; Natas, O.; Sepp, E.; Smidt, I.; Štšepetova, J.; Wornaes, J.; Naaber, P. (2009). Clostridium difficile resistance and ribitypes in Norway and Estonia. Clostridia: The Impact of Genomics on Disease Control: 6th ClostPath International Conference; Rome, Italy; 19.-23.10.2009. 75.
5.2.
2009
Jaanimäe, L.; Sepp, E.; Štšepetova, J.; Kõljalg, S.; Mikelsaar, M. (2009). Eesti nosokomiaalse Clostridium difficile tundlikkus antibiootikumidele. Eesti Arst, 9. 583.
5.2.
2009
Arbonen, A.; Arbo, T.; Sepp, E.; Kõljalg, S.; Štšepetova, J. (2009). Eestist isoleeritud metitsilliiniresistentse Staphylococcus aureus'e tundlikkus dekolonisatsiooniks kasutatavate preparaatide suhtes. Eesti Arst, 9. 603.
6.7.
2009
Songisepp, E.; Mikelsaar, M.; Rätsep, M.; Zilmer, M.; Zilmer , K.; Üksti, J.; Kõljalg, S. (2009). Isoleeritud mikroorganismi tüvi Lactobacillus plantarum Tensia DSM 21380 kui antimikroobne ja antihüpertensiivne probiotik, toiduprodukt ja Komposition mis sisaldab vastavat mikroorganismi ja selle mikroorganismi kasutus antihüpertensiivse ravimi valmistamiseks ja meetod patogeenide ja mitte-starter laktobatsillide allasurumiseks toiduproduktis. Espacenet, x−x.
1.3.
2008
Lõivukene, K.; Pähkla, E-R.; Koppel, T.; Kõljalg, S.; Kermes, K.; Allik, M.; Juhani, A.; Saag, M.; Adamson, V.; Mitt, P.; Sepp, E.; Truusalu, K.; Naaber, P. (2008). TÜ Kliinikumi ühendlaboris isoleeritud anaeroobide spekter ja ravimitundlikkus. Eesti Arst, 87 (11), 834−840.
5.2.
2008
Lõivukene, Krista; Kõljalg, Siiri; Kermes, Kadri; Allik, Merle; Juhani, Anneli; Adamson, Vivika; Telling, Kaidi; Ivanova, Marina; Naaber, Paul (2008). Fenotüübiliselt samastamiselt genotüübilisele: Mycobacterium fortuitum´i juhtum. Eesti Arst, 87: Arstiteaduskonna Teaduskonverents, Tartu 09.10 - 10.10.2008. OÜ Celsius Healthcare, 678. (9).
5.2.
2008
Truusalu, K.; Kõljalg, S.; Stsepetova, J.; Drell, T.; Vainumäe, I.; Sepp, E.; Mikelsaar, M. (2008). Persistence of Escherichia coli clones and resistance genes in recurrent urinary tract infections in children. 18th ECCMID; Barcelona; 20-24.04.2008. Hispaania, Barcelona,.
5.2.
2008
Songisepp, E.; Mikelsaar, M.; Zilmer, M.; Hütt, P.; Smidt, I.; Stsepetova, J.; Truusalu, K.; Rätsep, M.; Kilk, K.; Utt, M.; Üksti, J.; Kõljalg, S., Zilmer, K. (2008). Lactobacillus plantarum TENSIA (DSM 21380) and L. plantarum INDUCIA (DSM 21379) as novel probiotics. FIL-IDF World Dairy Summit, Mecixo City, Mexico, 11-14 November 2008. Mexico City,.
5.2.
2008
Truusalu, K.; Kõljalg, S.; Parm, Ü.; Sepp, E.; Metsvaht, T.; Naaber, P.; Lõivukene, K.; Lutsar, I. (2008). Staphylococcal Infection and Colonization of Pediatric Intensive Care Unit Patients: MRSA versus MRSE. Abstract book: Emerging Technologies of Medical Importance for the Diagnosis of Infectious Diseases and the Detection of Pathogenic Microbes. 1 st Intenational ASM Conference in Bejing, April 6-10, 2008. 44.
5.2.
2008
Mitt, P.; Adamson, V.; Truusalu, K.; Parm, Ü.; Kõljalg, S.; Sepp, E.; Lõivukene, K.; Lutsar, I.; Maimets, M. (2008). An outbreak of meticillin-resistant Staphylococcus aureus (spa type t008) in the paediatric intensive care unit of a university hospital, Tartu. Clinical Microbiology and Infection, 14: 18th European Congress of Clinical Microbiology and Infectious Diseases. Abstract number: P1439. (S7).
5.2.
2008
Stsepetova, J.; Kõljalg, S.; Sepp, E.; Lõivukene, K.; Songisepp, E.; Rätsep, M.; Mikelsaar, M. (2008). Antibiotic susceptibility pattern and tetracycline resistance of Lactobacillus strains of different origin. Clinical Microbiology and Infection, 14: 18th European Congress of Clinical Microbiology and Infectious Diseases. Abstract number: P1210. (S7).
1.1.
2007
Tamm, E.; Naaber, P.; Maimets, M.; Oona, M.; Kõljalg, S.; Lutsar, I. (2007). Antimicrobial susceptibility and serogroup/serotype distribution of nasopharyngeal isolates of Streptococcus pneumoniae in healthy Estonian children in 1999-2003. Clinical Microbiology and Infection, 13 (8), 824−826.10.1111/j.1469-0691.2007.01743.x.
5.2.
2007
Mitt, P.; Kõljalg, S.; Lõivukene, K.; Sepp, E.; Lutsar, I.; Maimets, M. (2007). Laboratory markers to determine clinical significance of coagulase-negative staphylococci in blood cultures. Sepsis 2007: An International Symposium; Institut Pasteur, Paris; September 27 - 29, 2007. 46−47.
1.3.
2003
Sepp, E.; Kõljalg, S.; Truusalu, K.; Štšepetova, L.; Metsvaht, T.; Sau, L.; Jürna, M.; Mägi, H.; Allik, M.; Mikelsaaar, M. (2003). Staphylococcus epidermidis ja Klebsiella pneumoniae - võimalikud hospitaalinfektsioonide tekitajad Eesti lasteintensiivravi osakondades. Eesti Arst, 82 (4), 239−248.
1.3.
2003
Tamm, E.; Kõljalg, S.; Lutsar, I.; Maimets, M.; Naaber, P. (2003). Pneumokokkinfektsioon lapseeas. Eesti Arst, 82 (7), 464−471.
1.1.
2002
Koljalg, S.; Naaber, P.; Mikelsaar, M. (2002). Antibiotic resistance as an indicator of bacterial chlorhexidine susceptibility. Journal of Hospital Infection, 51 (2), 106−113.
1.1.
2002
Olsson-Liljequist, B.; Koljalg, S.; Kronvall, G. (2002). Calibration of fusidic acid disk diffusion susceptibility testing of Staphylococcus aureus. APMIS, 110 (10), 690−696.
1.2.
2001
Kõljalg, S.; Naaber, P.; Mikelsaar, R.; Mikelsaar, M. (2001). Biocidal effect of protamine and melittin in combination with chlorhexidine. Clinical Microbiology and Infection, 7 (1), 32−34.
5.2.
2001
Järv, H.; Kõljalg, S.; Adamson, V.; Naaber, P.; Maimets, M. (2001). Oportunistlike seenpatogeenide esinemine intensiivhematoloogia ja luuüdi siirdamise osakonnas. Eesti Arst, 80 (9), 399.
5.2.
2001
Ruubas, I.; Järv, H.; Kõljalg, S.; Adamson, V.; Maimets, M.; Naaber, P. (2001). Vaginaalse kandidoosi raviks kasutatavate antifungaalsete preparaatide tundlikkuse määramine diskdifusiooni meetodiga. Eesti Arst, 80 (9), 416.
1.1.
2000
Naaber, P.; Koljalg, S.; Maimets, M. (2000). Antibiotic usage and resistance - trends in Estonian University Hospitals. International Journal of Antimicrobial Agents, 16 (3), 309−315.
1.1.
2000
Naaber, P.; Tamm, E.; Putsepp, A.; Koljalg, S.; Maimets, M. (2000). Nasopharyngeal carriage and antibacterial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Estonian children. Clinical Microbiology and Infection, 6 (12), 675−677.
1.3.
2000
Kõljalg, S.; Karki, T.; Olsson-Liljequist, B. (2000). Metsitsilliin-resistentse Staphylococcus aureus'e esinemissagedus Eestis. Eesti Arst, 79 (8), 466−470.
1.1.
1999
Koljalc, S.; Sults, I.; Raukas, E.; Truu, J.; Ustav, M.; Mikelsaar, M. (1999). Distribution of Acinetobacter baumannii in a neurointensive care unit. Scandinavian Journal of Infectious Diseases, 31 (2), 145−150.
2.3.
1999
Kõljalg, Siiri (1999). Acinetobacter - an important nosocomial pathogen. (Doktoritöö). Tartu Ülikooli Kirjastus.
5.2.
1999
Sepp, Epp; Naaber, Paul; Lõivukene, Krista; Kõljalg, Siiri; Voor, Tiia; Björkstén, Bengt; Mikelsaar, Marika (1999). Eesti laste sooletrakti mikrofloora kujunemine esimesel eluaastal. Arstiteaduskonna aastakonverents, 7. oktoober 1999 : teesid, 110−111.
1.1.
1997
Turi, M.; Turi, E.; Koljalg, S.; Mikelsaar, M. (1997). Influence of aqueous extracts of medicinal plants on surface hydrophobicity of Escherichia coli strains of different origin. APMIS, 105 (12), 956−962.
1.3.
1997
Sepp, E.; Lõivukene, K.; Naaber, P.; Kermes, K.; Kõljalg, S.; Julge, K.; Vasar, M.; Björksten, B.; Mikelsaar, M. (1997). Tervete ja allergiliste laste mikrofloora erinevused. Eesti Rohuteadlane, Lisa, 62−63.
1.1.
1996
Koljalg, S.; VuopioVarkila, J.; Lyytikainen, O.; Mikelsaar, M.; Wadstrom, T. (1996). Cell surface properties of Acinetobacter baumannii. APMIS, 104 (9), 659−665.
1.3.
1996
Kõljalg, S.; Kermes, K.; Lõivukene, K.; Naaber, P.; Mikelsaar, M. (1996). Kirurgilisi infektsioone tekitavad mikroorganismid ja nende antibiootikumtundlikkus. Eesti Arst, lisa, 39−40.

Tööstusomand

Siiri Kõljalg

https://www.etis.ee/CV/Siiri_Kõljalg/eng
737 4178
siiri.koljalg@ut.ee

Career

Institution and occupation
2006–...   
University of Tartu, Faculty of Medicine, Department of Microbiology, Extraordinary Researcher (1,00)
01.09.1999–...   
Tartu University Hospital, United Laboratories of Tartu University Hospital, clinical microbiologist, department of Clinical Microbiology (0,50)
01.01.1999–...   
University of Tartu, Faculty of Medicine, Department of Microbiology; Researcher
1991-1993 internship in Tartu University Clinics
01.11.2016–30.11.2017   
University of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine, Research Fellow in Medical Microbiology (0,50)
01.01.2016–31.10.2016   
University of Tartu, Faculty of Medicine, Institute of Biomedicine and Translational Medicine, Research Fellow in Medical Microbiology (0,50)
01.11.2013–31.12.2015   
University of Tartu, Faculty of Medicine, Department of Microbiology, Research Fellow in Medical Microbiology (0,50)
01.11.2010–31.10.2013   
University of Tartu, Faculty of Medicine, Department of Microbiology, Research Fellow in Medical Microbiology (0,50)
01.11.2007–31.10.2010   
University of Tartu, Faculty of Medicine, Department of Microbiology, Research Fellow (0,50)
2007–2010   
University of Tartu, Faculty of Medicine, Department of Microbiology, Chair of Medical Microbiology and Virology, mikrobioloogia teadur (1,00)
01.11.2004–31.10.2007   
University of Tartu, Faculty of Medicine, Department of Microbiology, Research Fellow extraordinarius (0,50)
 
 
Education
1983-1989 University of Tartu, Medical Faculty
1993-1998 University of Tartu, Department of Microbiology, postgraduate student

Qualifications

Academic degrees
Siiri Kõljalg, Doctor's Degree, 1999, (sup) Marika Mikelsaar, Acinetobacter - an important nosocomial pathogen, University of Tartu, Faculty of Medicine, Department of Microbiology.
 
 
Field of research
FIELD OF RESEARCH: 3. Health; 3.11. Biochemistry, Genetics, Microbiology, Biotechnology, Molecular Biology, Cell Biology, Biophysics and Bioinformatics relating to Health Studies
 
 
Additional information
Doctor of Medical Sciences
University of Tartu 1999

Projects in progress

Completed projects

Supervised dissertations

Publications

Category
Year
Publication
 
1.1.
2017
Ahonen, M.; Kahru, A.; Ivask, A.; Kasemets, K.; Kõljalg,S.; Mantecca, P.; Vinković Vrček, I.; Keinänen-Toivola, M.; Crijns, F. (2017). Proactive Approach for Safe Use of Antimicrobial Coatings in Healthcare Settings: Opinion of the COST Action Network AMiCI. International Journal of Environmental Research and Public Health, 14 (4), 366.10.3390/ijerph14040366.
1.1.
2016
Mändar, Karsten; Sõber, Tiina; Kõljalg, Siiri; Rööp, Tiiu; Mändar, Reet; Sepp, Epp. (2016). Microbiological contamination of the euro currency in Estonia. Infectious Diseases, 48 (10), 772−774.10.1080/23744235.2016.1201725.
1.1.
2016
Bielicki, J.A., Sharland, M., Johnson, A.P., Henderson, K.L., Cromwell, D.A. , Berger, C., Esposito, S., Danieli, E., Tenconi, R., Folgori, L., Bernaschi, P., Santiago, B., Saavedra, J., Cercenado, E., Brett, A., Rodrigues, F., Cizman, M., Jazbec, J., Babnik, J., Pavčnik, M., Pirš, M., Mueller Premrov, M., Lindner, M., Borte, M., Lippmann, N., Schuster, V., Thürmer, A., Lander, F., Elias, J., Liese, J., Durst, A., Weichert, S., Schneider, C., Hufnagel, M., Rack, A., Hübner, J., Dubos, F., Lagree, M., Dessein, R., Tissieres, P., Cuzon, G., Gajdos, V., Doucet-Populaire, F., Usonis, V., Gurksniene, V., Bernatoniene, G., Tsolia, M., Spyridis, N., Lebessi, E., Doudoulakakis, A., Lutsar, I., Kõljalg, S., Schülin, T., Warris, A. (2016). Selecting appropriate empirical antibiotic regimens for paediatric bloodstream infections: Application of a Bayesian decision model to local and pooled antimicroabial resistance surveillance data. Journal of Antimicrobial Chemotherapy, 71 (3), 794−802.10.1093/jac/dkv397.
5.2.
2016
Pavelkovich, A.; Ivanova, M.; Kõljalg, S.; Naaber, P.; Pai, K.; Sepp, E.; BEEp research team (2016). Epidemiology of AB resistant gram-negative bacteria in the Baltic Sea region. Eesti Arst, 95 (Supplement1): XIII Baltic Congress in Laboratory Medicine; Tartu, Estonia; May 12-14 2016. OÜ Celsius Healthcare, 39.
5.2.
2015
Naaber, Paul; Balode, Arta; Egorova, Svetlana; Huik, Kristi; Ivanova, Marina; Kaftyreva, Lidia; Kõljalg, Siiri; Kõressaar, Triinu; Lillo, Jana; Löhr, Iren; Miciuleviciene, Jolanta; Pai, Kristiine; Pavelkovich, Anastassia; Remm, Maido; Sepp, Epp (2015). The epidemiology of CTX-M group genes among clinical Escherichia coli strains in Estonia, Latvia, Lithuania, Norway and Russia.
5.2.
2015
Truusalu, Kai; Vainumäe, Inga; Stsepetova, Jelena; Smidt, Imbi; Sepp, Epp; Mikelsaar, Marika; Kõljalg, Siiri (2015). The impact of the initial antibiotic treatment to subsequent recurrences in childhood urinary tract infection caused by Escherichia coli: beta-lactams vs gentamicin. In: .ECCMID 2015 Copenhagen, Denmark, 25-28 April 2015. ECCMID 2015 Copenhagen, Denmark, 25-28 April 2015.
1.1.
2014
Kõljalg, S.; Telling, K.; Huik, K.; Murruste, M.; Saarevet, V.; Pauskar, M.; Lutsar, I. (2014). First report of Wohlfahrtiimonas chitiniclastica from soft tissue and bone infection at an unusually high northern latitude. Folia Microbiologica, 60 (2), 155−158.10.1007/s12223-014-0355-x.
1.1.
2014
Lillo, Jana; Pai, Kristiine; Bolde, Arta; Makarova, Mariia; Huik, Kristi; Kõljalg, Siiri; Ivanova, Marina; Kaftyreva, Lidia; Miciuleviciene, Jolanata; Naaber, Paul; Parv, Kristel; Pavelkovich, Anastasia; Rööp, Tiiu; Toompere, Karolin; Suzhaeva, Ludmila; Sepp, Epp (2014). Differences in extended-spectrum beta-lactamase producing Escherichia coli virulence factor genes in the Baltic Sea region. BioMed Research International, 427254, 1−7.10.1155/2014/427254.
1.1.
2014
Pavelkovich, Anastasia; Balode, Arta; Edquist, Petra; Egorova, Svetlana; Ivanova, Marina; Kaftyreva, Lidia; Konovalenko, Irina; Kõljalg, Siiri; Lillo, Jana; Lipskaya, Lidia; Miciuleviciene, Jolanta; Pai, Kristiine; Parv, Kristel; Pärna, Katri; Rööp, Tiiu; Sepp, Epp; Štšepetova, Jelena; Naaber, Paul (2014). Detection of Carbapenemase-Producing Enterobacteriaceae in the Baltic Countries and St. Petersburg Area. BioMed Research International, 2014, Article 548960.10.1155/2014/548960.
1.1.
2014
Kõljalg, Siiri; Truusalu, Kai; Štšepetova, Jelena; Pai, Kristiine; Vainumäe, Inga; Sepp, Epp; Mikelsaar, Marika (2014). The Escherichia coli phylogenetic group B2 with integrons prevails in childhood recurrent urinary tract infections. APMIS, 122 (5), 452−458.10.1111/apm.12167.
1.2.
2014
Rätsep, Merle; Naaber, Paul; Kõljalg, Siiri; Shkut, Elena; Sepp, Epp (2014). Effect of Lactobacillus Strain on Clinical Isoletes of Clostridium difficile in vitro. Journal of Probiotics and Health, 2, 1−5.10.4172/2329-8901.1000119.
5.1.
2014
Truusalu, K; Smidt, I; Hütt, P; Stsepetova, J; Vainumäe, I; Sepp, E; Mikelsaar, M; Kõljalg, S. (2014). Comparison of phylogenetic groups, antibacterial resistance and integron containment of Escherichia coli from initial episode of childhood urinary tract infections with different outcomes. 24th European Congress of Clinical Microbiology and Infectious Diseases in Barcelona, Spain, 10 – 13 May 2014.. x, x.
5.2.
2014
Pärna, K.; Balode, A.; Edquist, A.; Egorova, P.; Kaftyreva, S.; Miciuleviciene, L.; Ivanova, M.; Kõljalg, S.; Pai, K.; Pavelkovich, A.; Rööp, T.; Sepp, E.; Naaber, P.; Stsepetova, J. (2014). Detection of class 1, 2 and 3 integrons among extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated from Baltic sea region. European Congress of Cilinical Microbiology and Infestious Diseases, Barcelona, Spain, 10-13 May 2014. x, x.
5.2.
2014
Pai, K.; Huik, K.; Ivanova, M.; Kõljalg, S.; Pavelkovich, K.; Parv, K.; Rööp, T.; Sepp, E.; Naaber, P. (2014). Detection and molecular characterisation of extended-spectrum beta-lactamase-producing Escherichia coli sequence type ST131 from the Baltic region. European Congress of Clinical Microbiology and Infectious Diseases, Barcelona, Spain, 10-13 May 2014.
1.1.
2013
Brilene, T.; Soeorg, H.; Kiis, M.; Sepp, E.; Kõljalg, S.; Lõivukene, K.; Jürna-Ellam, M.; Kalinina, J.; Stšepetova, J.; Metsvaht, T.; Lutsar, I. (2013). In vitro synergy of oxacillin and gentamicin against coagulase-negative staphylococci from blood cultures of neonates with late-onset sepsis. APMIS, 121 (9), 859−864.10.1111/apm.12048.
1.3.
2013
Егорова, СА; Кафтыреща, ЛА; Липская, ЛВ; Коноваленко, ИБ; Пясетская, МФ; Курчикова, ТС; Ведерникова, НБ; Морозова, ОТ; Смирнова, МБ; Попенко, ЛН; Любушкина, МИ; Савочкина, ЮА; Макарова, МА; Сужаева, ЛВ; Останкова, ЮВ; Иванова, МН; Павелкович, АМ; Наабер, П; Сепп, Э; Кыльялг, С ... Балоде, А. (2013). Штаммы энтеробактерий, продуцирующие бета-лактамазы пасширенного спектра и металло-В-лактамазу НДМ-1, выделенные в стационарах в странах Балтийского региона. Инфекция и иммунитет, 3 (1), 29−36.
5.2.
2013
Lillo, J; Balode, A; Egorova, S; Huik, K; Ivanova, M; Kaftyreva, L; Makarova, M; Miciuleviciene, J; Naaber, P; Pai, K; Parv, K; Pavelkovich, A; Rööp, T; Sepp, E. (2013). Differences in virulence factors of Escherichia coli isolated from the Baltic Sea region. 23 nd European Congress ofClinical Microbiology and Infectious Diseases; Berlin; 27-30 April 2013.
5.2.
2013
Naaber, P; Balode, A; Djundika, T; Egorova, S; Huik, K; Kaftyreva, L; Kamõnina, N; Kirs, K; Kõljalg, S; Konovalenko, I; Kurchikova, T; Lillo, J; Lipskaya, L; Lõivukene, L; Makarova, M; Makstutis, G; Miciuleviciene, J; Morozova, O; Pai, K; Parv, K ... Ivanova, M (2013). Epidemiology of extended-spectrum beta-lactamases-producing Escherichia coli and Klebsiella pneumoniae in the Baltic Sea region. 23 nd European Congress ofClinical Microbiology and Infectious Diseases; Berlin; 27-30 April 2013.
5.2.
2013
Pai, K; Balode, B; Egorova, S; Huik, K; Ivanova, M; Kaftyreva, L; Kõljalg, S; Lillo, J; Miciuleviciene, J; Naaber, P; Parv, K; Pavelkovich, A; Rööp, T; Sepp, E. (2013). The molecular epidemiology of extended-spectrum beta-lactamases-producing Escherichia coli and Klebsiella pneumoniae in the Baltic Sea region. 23 nd European Congress ofClinical Microbiology and Infectious Diseases; Berlin; 27-30 April 2013.
5.2.
2013
Rätsep, Merle; Naaber, Paul; Kõljalg, Siiri; Smidt, Imbi; Shkut, Leena; Sepp, Epp (2013). Antagonistic activity of culture supernatant of lactobacilli against the growth of Clostridium difficile in vitro. ClostPath 2013 Meeting; Palm Cove, Australia; 22.-26. October 2013.
5.2.
2013
Pavelkovich, A; Balode, A; Edquist, P; Egorova, S; Ivanova, M; Kaftyreva, L; Kõljalg, S; Lillo, J; Lipskaya, L; Miciuleviciene, J; Pai, K; Sepp, E; Sparbier, K; Naaber, P (2013). Detection of carbapenem-non-susceptible Escherichia coli and Klebsiella pneumoniae in the Baltic Sea region. 23nd European Congress ofClinical Microbiology and Infectious Diseases; Berlin; 27-30 April 2013..
1.1.
2012
Songisepp, E.; Hütt, P.; Rätsep, M.; Shkut, E.; Kõljalg, S.; Truusalu, K.; Stsepetova, J.; Smidt, I.; Kolk, H.; Zagura, M.; Mikelsaar, M. (2012). Safety of probiotic cheese containing Lactobacillus plantarum Tensia according to a variety of health indices in different age groups. Journal of Dairy Science, 95 (10), 5495−5509.dx.doi.org/10.3168/jds.2011-4756.
5.2.
2012
Kõljalg, S.; Truusalu, K.; Stsepetova, J.; Pai, K.; Vainumäe, I.; Hütt, P.; Smidt, I.; Mändar, R.; Sepp, E.; Mikelsaar, M. (2012). The role of phylogenetic groups of Escherichia coli in childhood recurrent urinary tract infections. 22nd European Congress ofClinical Microbiology and Infectious Diseases, London, United Kingdom, 31 March – 3 April 2012.
5.2.
2012
Naaber, P.; Sepp, E.; Pai, K.; LilĮo, J.; Pavelkovich, A.; Stsepetova, J .; Ivanova, M.; Lõįvukene, K.; Kõljalg, S. (2012). Molecular Epidemiology of Extended Spectrum Beta-Lactamases (ESBLs) in Estonia. BIT's 2nd Annual World Congress of Microbes-2012(WCM-2012), Guangzhou, China, July 30-August 1, 2012.
5.2.
2012
Kõljalg, S.; Naaber, P.; Rätsep, M.; Smidt, I.; Shkut, J.; Jaanimäe, L.; Löhr, L.H; ,Stsepetova, J.; Mändar, R.; Sepp, E. (2012). Population dynamics and sporulation of quinolone resistant and sensitive Clostridium difficile strains in different environmental conditions. 4th International Clostridium difficile Symposium; Bled, Slovenia, September 20-22, 2012.
1.1.
2011
Sepp, Epp; Stšepetova, Jelena; Smidt, Imbi; Rätsep, Merle; Kõljalg, Siiri; Lõivukene, Krista; Mändar, Reet; Jaanimäe, Liis; Löhr, IH; Natås, OB; Naaber, Paul (2011). Intestinal lactoflora in Estonian and Norwegian patients with antibiotic associated diarrhea. Anaerobe, 17, 407−409.
1.1.
2011
Naaber, Paul; Stsepetova, Jelena; Smidt, Imbi; Rätsep, Merle; Kõljalg, Siiri; Lõivukene, Krista; Jaanimäe, Liis; Löhr, Iren; Natås, Olav; Truusalu, Kai; Sepp, Epp (2011). Quantification of Clostridium difficile in Antibiotic-Associated Diarrhea Patients. Journal of Clinical Microbiology, 49 (10), 3656−3658.10.1128/JCM.05115-11.
5.2.
2011
Tiina, Drell; Jelena, Stsepetova; Irja, Lutsar; Tuuli, Metsvaht; Ülle, Parm; Kaja, Julge; Mari-Liis, Ilmoja; Maie, Jürisson; Siiri, Kõljalg; Paul, Naaber; Epp, Sepp (2011). Application of quantitative Real-time PCR for investigation on intestinal microbiota in pre-and full-term infants. 2nd ASMET-The ASM Emerging Technologies Conference: ASMET Conferences; San Juan, Pueto Rico; March 8-11, 2011. 45−46.
5.2.
2011
Naaber, Paul; Jelena , Stsepetova; Imbi, Smidt; Elena, Shkut; Merele, Rätsep; Siiri, Kõljalg; krista, Lõivukene; Reet, Mändar; Iren, Löhr; Olav, Natas; Epp, Sepp (2011). Application of molecular methods for invetigation og intestinallactoflora and Clostridium difficile in antibiotic-associated diarrhea patients. 2nd ASMET-The ASM Emerging Technologies Conference: ASMET Conferences; San Juan, Pueto Rico; March 8-11, 2011. USA, 41−42.
5.2.
2011
Kõljalg, S.; Stsepetova, J.; Smidt, I., Löhr, I; Truusalu, K.; Naaber, P.; Sepp, E. (2011). Antibiotic susceptibility, class I integrons and sporulation activity of Clostridium difficile strains from antibiotic-associated diarrhoea patients in two different years in Estonia and Norway. 21th ECCMID Milano, Italy 7-10 May 2011.
5.2.
2011
Naaber, P.; Smidt, I.; Rätsep, M.; Kõljalg, S.; Shkut, E.; Sepp, E. (2011). Strain-specific susceptibility of Clostridium difficile to inhibitory activity of Lactobacillus plantarum in vitro. 7th International Conference on the Molecular Biology and Pathogenesis of the Clostridia, 2011 Ames, Iowa USA.
5.2.
2011
Kõljalg, S.; Rätsep, M.; Stsepetova, J.; Smidt, I.; Shkut, E.; Naaber, P.; Sepp, E. (2011). Sporulation level of Clostridium difficile integron positive and negative strains in the presence of lactobacilli. 7th International Conference on the Molecular Biology and Pathogenesis of the Clostridia, 2011 Ames, Iowa USA.
5.2.
2011
Songisepp, Epp; Hütt, Pirje; Rätsep, Merle; Shkut, Elena; Zilmer, Mihkel; Kõljalg, Siiri; Truusalu, Kai; Smidt, Imbi; i Kolk, Helg; Zagura, Maksim; Mikelsaar, Marika (2011). Safety of a probiotic cheese comprising L. plantarum TENSIA according variety of health indices in different age groups. 6th Probiotics Prebiotics New Foods. 48.
1.3.
2010
Lõivukene, Krista; Adamson, Vivika; Mitt, Piret; Kõljalg, Siiri; Sepp, Epp; Ivanova, Marina; Jürna-Ellam, Marika; Kirs, Kaisa; Nurk, Allan; Rõõm, Aino; Truusalu, Kai; Naaber, Paul (2010). Metitsilliiniresistentse Staphylococcus aureus’e osakaal, esmasavaldumus ja antibiootikumiresistentsus Eestis. Eesti Arst, 89 (10), 630−636.
5.1.
2010
Naaber, Paul; Stsepetova, Jelena; Smidt, Imbi; Shkut, Elena; Rätsep, Merele; Kõljalg, Siiri; Lõivukene, Krista; Mänadar, Reet; Löhr, Irene; Natas, Borg; Sepp, Epp (2010). Intestinal Lactroflora in Patients with Antibiotic Associated Diarrhea (AAD). XXXIII Inernational Congress on Microbial Ecology and Diseases, Greece 6-10 September 2010. Greece, 22.
5.2.
2010
Smidt, I.; Sepp, E.; Rätsep, M.; Kõljalg, S.; Lõivukene, K.; Löhr, I.; Natas, O.; Mändar, R.; Naaber, P. (2010). Quantitative evaluation of Clostridium difficile and intestinal lactobacilli in patients with associated diarrhoea. Clinical Microbiology and Infection, 16: 20th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria 10-13 april 2010. S575. (2).
5.2.
2010
Naaber, P.; Truusalu, K.; Smidt, I.; Kõljalg, S.; Sepp, E.; Hütt, P.; Mändar, R.; Mikelsaar, M. (2010). Protective effect of xylitol and lactobacilli against Clostridium difficile infection in hamster model. Clinical Microbiology and Infection, 16 : 20th ECCMID, Vienna, Austria 10-13 April 2010. (2).
5.2.
2010
Arbo, Triin; Arbonen, Anne; Sepp, Epp; Stsepetova, Jelena; Kõljalg, Siiri; Lõivukene, Krista (2010). Eestist isoleeritud metitsilliinresistentse Staphylococcus aureus'e feno-ja genotüübilise diagnostika võrdlus. Eest Arst, 9: TÜ Arstiteaduskonna aastapäev 2010. 605.
5.2.
2010
Naaber, Paul; Stsepetova, Jelena; Smidt, Imbi; Shkut, Elena; Rätsep, Merle; Kõljalg, Siiri; Lõivukene, Krista; Mändar, Reet; Löhr, Irene; Natas, Borg; Sepp, Epp (2010). Intestinal Lactroflora in Patients with Antibiotic Associated Diarrhea (AAD). XXXIII International Congress of the Society for Microbial Ecology in Health and Disease; Greece; September 6-10, 2010. 22.
1.1.
2009
Sepp, E.; Stsepetova, J.; Lõivukene, K.; Truusalu, K.; Kõljalg, S.; Naaber, P.; Mikelsaar, M. (2009). The occurrence of antimicrobial resistance and class 1 integrons among commensal Escherichia coli isolates from infants and elderly persons. Annals of Clinical Microbiology and Antimicrobials, 8 (34), 1−6.
1.1.
2009
Kõljalg, S.; Truusalu, K.; Vainumäe, I.; Štšepetova, J.; Sepp, E.; Mikelsaar, M. (2009). Persistence of Escherichia coli clones and phenotypic and genotypic antibiotic resistance in recurrent tract infections in childhood. Journal of Clinical Microbiology, 47 (1), 99−105.10.1128/JCM.01419-08.
3.4.
2009
Songisepp, E.; Zilmer, M.; Hütt, P., Rätsep, M.; Utt, M.; Üksti, J.; Kõljalg, S.; Zilmer, K.; Mikelsaar, M. (2009). Lactobacillus plantarum TENSIA™ (DSM 21380) as a novel probiotic. Гастроэнтерология Санкт-Петербурга, 4. A25.
5.2.
2009
Lõivukene, K; Adamson, V; Ivanova, M; Jürna-Ellam, M; Kirs, K; Kõljalg, S; Mitt, P; Nurk, A; Rõõm, A; Sepp, E;i Truusalu, K; Naaber, P. (2009). Incidence and antimicrobial susceptibility pattern of methicillin-resistant Staphylococcus aureus isolates in Estonia.
5.2.
2009
Sepp, E.; Kõjalg, S.; Stsepetova, J., Smidt, I.; Rätsep, M.; Jaanimäe, L.; Naaber, P. (2009). Quantitative evaluation of lactobacilli and Clostridium difficile in faeces of patients with antibiotic associated diarrhoea and antibiotic resistance isolated strains. Fostering Cross-disciplinary Applied Research in Microbiology and Microbial Biotechnology: III International Conference on Environmental, Industrial and Applied Microbiology, BioMicroWorld 2009; Lisboa, Portugal; 2.-4.12.2009. 543.
5.2.
2009
Löhr, I.; Jaanimäe, L.; Kindingstad, L.; Kõljalg, S.; Natas, O.; Sepp, E.; Smidt, I.; Štšepetova, J.; Wornaes, J.; Naaber, P. (2009). Clostridium difficile resistance and ribitypes in Norway and Estonia. Clostridia: The Impact of Genomics on Disease Control: 6th ClostPath International Conference; Rome, Italy; 19.-23.10.2009. 75.
5.2.
2009
Jaanimäe, L.; Sepp, E.; Štšepetova, J.; Kõljalg, S.; Mikelsaar, M. (2009). Eesti nosokomiaalse Clostridium difficile tundlikkus antibiootikumidele. Eesti Arst, 9. 583.
5.2.
2009
Arbonen, A.; Arbo, T.; Sepp, E.; Kõljalg, S.; Štšepetova, J. (2009). Eestist isoleeritud metitsilliiniresistentse Staphylococcus aureus'e tundlikkus dekolonisatsiooniks kasutatavate preparaatide suhtes. Eesti Arst, 9. 603.
6.7.
2009
Songisepp, E.; Mikelsaar, M.; Rätsep, M.; Zilmer, M.; Zilmer , K.; Üksti, J.; Kõljalg, S. (2009). Isoleeritud mikroorganismi tüvi Lactobacillus plantarum Tensia DSM 21380 kui antimikroobne ja antihüpertensiivne probiotik, toiduprodukt ja Komposition mis sisaldab vastavat mikroorganismi ja selle mikroorganismi kasutus antihüpertensiivse ravimi valmistamiseks ja meetod patogeenide ja mitte-starter laktobatsillide allasurumiseks toiduproduktis. Espacenet, x−x.
1.3.
2008
Lõivukene, K.; Pähkla, E-R.; Koppel, T.; Kõljalg, S.; Kermes, K.; Allik, M.; Juhani, A.; Saag, M.; Adamson, V.; Mitt, P.; Sepp, E.; Truusalu, K.; Naaber, P. (2008). TÜ Kliinikumi ühendlaboris isoleeritud anaeroobide spekter ja ravimitundlikkus. Eesti Arst, 87 (11), 834−840.
5.2.
2008
Lõivukene, Krista; Kõljalg, Siiri; Kermes, Kadri; Allik, Merle; Juhani, Anneli; Adamson, Vivika; Telling, Kaidi; Ivanova, Marina; Naaber, Paul (2008). Fenotüübiliselt samastamiselt genotüübilisele: Mycobacterium fortuitum´i juhtum. Eesti Arst, 87: Arstiteaduskonna Teaduskonverents, Tartu 09.10 - 10.10.2008. OÜ Celsius Healthcare, 678. (9).
5.2.
2008
Truusalu, K.; Kõljalg, S.; Stsepetova, J.; Drell, T.; Vainumäe, I.; Sepp, E.; Mikelsaar, M. (2008). Persistence of Escherichia coli clones and resistance genes in recurrent urinary tract infections in children. 18th ECCMID; Barcelona; 20-24.04.2008. Hispaania, Barcelona,.
5.2.
2008
Songisepp, E.; Mikelsaar, M.; Zilmer, M.; Hütt, P.; Smidt, I.; Stsepetova, J.; Truusalu, K.; Rätsep, M.; Kilk, K.; Utt, M.; Üksti, J.; Kõljalg, S., Zilmer, K. (2008). Lactobacillus plantarum TENSIA (DSM 21380) and L. plantarum INDUCIA (DSM 21379) as novel probiotics. FIL-IDF World Dairy Summit, Mecixo City, Mexico, 11-14 November 2008. Mexico City,.
5.2.
2008
Truusalu, K.; Kõljalg, S.; Parm, Ü.; Sepp, E.; Metsvaht, T.; Naaber, P.; Lõivukene, K.; Lutsar, I. (2008). Staphylococcal Infection and Colonization of Pediatric Intensive Care Unit Patients: MRSA versus MRSE. Abstract book: Emerging Technologies of Medical Importance for the Diagnosis of Infectious Diseases and the Detection of Pathogenic Microbes. 1 st Intenational ASM Conference in Bejing, April 6-10, 2008. 44.
5.2.
2008
Mitt, P.; Adamson, V.; Truusalu, K.; Parm, Ü.; Kõljalg, S.; Sepp, E.; Lõivukene, K.; Lutsar, I.; Maimets, M. (2008). An outbreak of meticillin-resistant Staphylococcus aureus (spa type t008) in the paediatric intensive care unit of a university hospital, Tartu. Clinical Microbiology and Infection, 14: 18th European Congress of Clinical Microbiology and Infectious Diseases. Abstract number: P1439. (S7).
5.2.
2008
Stsepetova, J.; Kõljalg, S.; Sepp, E.; Lõivukene, K.; Songisepp, E.; Rätsep, M.; Mikelsaar, M. (2008). Antibiotic susceptibility pattern and tetracycline resistance of Lactobacillus strains of different origin. Clinical Microbiology and Infection, 14: 18th European Congress of Clinical Microbiology and Infectious Diseases. Abstract number: P1210. (S7).
1.1.
2007
Tamm, E.; Naaber, P.; Maimets, M.; Oona, M.; Kõljalg, S.; Lutsar, I. (2007). Antimicrobial susceptibility and serogroup/serotype distribution of nasopharyngeal isolates of Streptococcus pneumoniae in healthy Estonian children in 1999-2003. Clinical Microbiology and Infection, 13 (8), 824−826.10.1111/j.1469-0691.2007.01743.x.
5.2.
2007
Mitt, P.; Kõljalg, S.; Lõivukene, K.; Sepp, E.; Lutsar, I.; Maimets, M. (2007). Laboratory markers to determine clinical significance of coagulase-negative staphylococci in blood cultures. Sepsis 2007: An International Symposium; Institut Pasteur, Paris; September 27 - 29, 2007. 46−47.
1.3.
2003
Sepp, E.; Kõljalg, S.; Truusalu, K.; Štšepetova, L.; Metsvaht, T.; Sau, L.; Jürna, M.; Mägi, H.; Allik, M.; Mikelsaaar, M. (2003). Staphylococcus epidermidis ja Klebsiella pneumoniae - võimalikud hospitaalinfektsioonide tekitajad Eesti lasteintensiivravi osakondades. Eesti Arst, 82 (4), 239−248.
1.3.
2003
Tamm, E.; Kõljalg, S.; Lutsar, I.; Maimets, M.; Naaber, P. (2003). Pneumokokkinfektsioon lapseeas. Eesti Arst, 82 (7), 464−471.
1.1.
2002
Koljalg, S.; Naaber, P.; Mikelsaar, M. (2002). Antibiotic resistance as an indicator of bacterial chlorhexidine susceptibility. Journal of Hospital Infection, 51 (2), 106−113.
1.1.
2002
Olsson-Liljequist, B.; Koljalg, S.; Kronvall, G. (2002). Calibration of fusidic acid disk diffusion susceptibility testing of Staphylococcus aureus. APMIS, 110 (10), 690−696.
1.2.
2001
Kõljalg, S.; Naaber, P.; Mikelsaar, R.; Mikelsaar, M. (2001). Biocidal effect of protamine and melittin in combination with chlorhexidine. Clinical Microbiology and Infection, 7 (1), 32−34.
5.2.
2001
Järv, H.; Kõljalg, S.; Adamson, V.; Naaber, P.; Maimets, M. (2001). Oportunistlike seenpatogeenide esinemine intensiivhematoloogia ja luuüdi siirdamise osakonnas. Eesti Arst, 80 (9), 399.
5.2.
2001
Ruubas, I.; Järv, H.; Kõljalg, S.; Adamson, V.; Maimets, M.; Naaber, P. (2001). Vaginaalse kandidoosi raviks kasutatavate antifungaalsete preparaatide tundlikkuse määramine diskdifusiooni meetodiga. Eesti Arst, 80 (9), 416.
1.1.
2000
Naaber, P.; Koljalg, S.; Maimets, M. (2000). Antibiotic usage and resistance - trends in Estonian University Hospitals. International Journal of Antimicrobial Agents, 16 (3), 309−315.
1.1.
2000
Naaber, P.; Tamm, E.; Putsepp, A.; Koljalg, S.; Maimets, M. (2000). Nasopharyngeal carriage and antibacterial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Estonian children. Clinical Microbiology and Infection, 6 (12), 675−677.
1.3.
2000
Kõljalg, S.; Karki, T.; Olsson-Liljequist, B. (2000). Metsitsilliin-resistentse Staphylococcus aureus'e esinemissagedus Eestis. Eesti Arst, 79 (8), 466−470.
1.1.
1999
Koljalc, S.; Sults, I.; Raukas, E.; Truu, J.; Ustav, M.; Mikelsaar, M. (1999). Distribution of Acinetobacter baumannii in a neurointensive care unit. Scandinavian Journal of Infectious Diseases, 31 (2), 145−150.
2.3.
1999
Kõljalg, Siiri (1999). Acinetobacter - an important nosocomial pathogen. (Doktoritöö). Tartu Ülikooli Kirjastus.
5.2.
1999
Sepp, Epp; Naaber, Paul; Lõivukene, Krista; Kõljalg, Siiri; Voor, Tiia; Björkstén, Bengt; Mikelsaar, Marika (1999). Eesti laste sooletrakti mikrofloora kujunemine esimesel eluaastal. Arstiteaduskonna aastakonverents, 7. oktoober 1999 : teesid, 110−111.
1.1.
1997
Turi, M.; Turi, E.; Koljalg, S.; Mikelsaar, M. (1997). Influence of aqueous extracts of medicinal plants on surface hydrophobicity of Escherichia coli strains of different origin. APMIS, 105 (12), 956−962.
1.3.
1997
Sepp, E.; Lõivukene, K.; Naaber, P.; Kermes, K.; Kõljalg, S.; Julge, K.; Vasar, M.; Björksten, B.; Mikelsaar, M. (1997). Tervete ja allergiliste laste mikrofloora erinevused. Eesti Rohuteadlane, Lisa, 62−63.
1.1.
1996
Koljalg, S.; VuopioVarkila, J.; Lyytikainen, O.; Mikelsaar, M.; Wadstrom, T. (1996). Cell surface properties of Acinetobacter baumannii. APMIS, 104 (9), 659−665.
1.3.
1996
Kõljalg, S.; Kermes, K.; Lõivukene, K.; Naaber, P.; Mikelsaar, M. (1996). Kirurgilisi infektsioone tekitavad mikroorganismid ja nende antibiootikumtundlikkus. Eesti Arst, lisa, 39−40.

Industrial property